A Single Centre, Two-period, Open Label, Randomised, Cross-over Study to Assess Plasma Levodopa, Carbidopa and Entacapone Concentrations After Continuous Infusion of TRIGEL or Duodopa in Patients With Advanced Parkinson´s Disease
This study evaluates the continuous addition of entacapone to infused levodopa and carbidopa on the pharmacokinetic (PK) profile in patients with advanced Parkinson's disease (PD). All patients will receive both study drugs, i.e. TRIGEL (levodopa, carbidopa, and entacapone) and Duodopa (levodopa and carbidopa), in randomized order.
100 项与 Lobsor Pharmaceuticals AB 相关的临床结果
0 项与 Lobsor Pharmaceuticals AB 相关的专利(医药)
100 项与 Lobsor Pharmaceuticals AB 相关的药物交易
100 项与 Lobsor Pharmaceuticals AB 相关的转化医学